Bookbuilding IPO | ₹[.] Cr | Listing at BSE, NSE |
SEBI has approved the Initial Public Offer (IPO) of Cotec Healthcare Ltd. on May 18, 2026. The company will proceed with next steps to launch the Initial Public Offer (IPO) subject to market conditions and other approvals. The SEBI approval is valid for 12 months.
Cotec Healthcare Ltd. IPO is a Book Build Issue consisting of fresh issue of ₹295.00 crores and an offer for sale (OFS) of upto 0.60 crore equity shares.
The equity shares are proposed to be listed on NSE and BSE. Pantomath Capital Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. Key details like IPO dates, IPO price bands and lot size are yet to be announced.
Refer to Cotec Healthcare IPO DRHP for more details.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹5 per share |
| Price Band | |
| Lot Size | |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Fresh Issue | [.] shares (agg. up to ₹295 Cr) |
| Offer for Sale | 60,00,000 shares of ₹5 (agg. up to ₹[.] Cr) |
| Share Holding Pre Issue | 11,42,06,346 shares |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Wed, Sep 10, 2025 |
| SEBI/Exchange approval received | Mon, May 18, 2026 |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Offer |
| Retail Shares Offered | Not less than 35% of the Offer |
| NII Shares Offered | Not less than 15% of the Offer |
Incorporated in 1998, Cotec Healthcare Limited operates as a Contract Development and Manufacturing Organization (CDMO) with capabilities across 24 distinct formulation types. The company manufactures a wide range of products including injectables, tablets, capsules, ointments, eye drops, ampoules, vials, liquid and dry syrups, and infusions.
Its portfolio covers multiple therapeutic areas such as anaesthetics, analgesic/anti-inflammatory, antibiotics, anti-asthmatics, cardiovascular, dermatology, endocrinology and women’s health, clinical nutrition, vitamins, multivitamins, multimineral & supplements, and others.
The company’s manufacturing facility is located in Roorkee, Uttarakhand, covering 21,871.71 square meters, with an installed capacity of 4,051.38 million units as of March 31, 2025.
Cotec Healthcare Limited served 154, 177, and 122 customers during Fiscal 2025, 2024, and 2023, respectively. Key CDMO customers include Mankind Pharma Limited, German Remedies Pharmaceuticals Private Limited, Albert David Limited, Bion Therapeutics India Private Limited, Jagsonpal Pharmaceuticals Limited, and Makers Laboratories Limited.
The company’s operations span both domestic and international markets, supplying products across 24 states and union territories in India and exporting to 14 countries.
Cotec Healthcare Limited plans to expand exports to regions including Central Asia, Africa, the Commonwealth of Independent States, Latin America, Europe, and the Middle East.
As of August 31, 2025, Cotec Healthcare Limited employed 419 permanent employees and 203 contract workers.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 136.63 | 95.83 | 68.65 |
| Total Income | 192.87 | 138.44 | 82.66 |
| Profit After Tax | 5.03 | 10.46 | 20.00 |
| EBITDA | 31.44 | 17.12 | 9.51 |
| NET Worth | 58.97 | 38.90 | 28.34 |
| Total Borrowing | 26.07 | 15.49 | 11.24 |
| Amount in ₹ Crore | |||
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Hexagon Nutrition Ltd. | Mainboard | ₹138.87 Cr | ₹45 | 22.69 | ₹53.19 | +18.20% | ₹74.97 (-1.54%) |
| Sai Parenteral's Ltd. | Mainboard | ₹408.79 Cr | ₹392 | 72.19 | ₹405.70 | +3.49% | ₹566.85 (-2.93%) |
| Corona Remedies Ltd. | Mainboard | ₹655.37 Cr | ₹1062 | 43.47 | ₹1,438.40 | +35.44% | ₹2,063.40 (+0.91%) |
| Rubicon Research Ltd. | Mainboard | ₹1,377.50 Cr | ₹485 | 55.75 | ₹628.20 | +29.53% | ₹1,451.10 (-2.70%) |
| Amanta Healthcare Ltd. | Mainboard | ₹126.00 Cr | ₹126 | 34.59 | ₹141.75 | +12.50% | ₹168.64 (-2.00%) |
| Anlon Healthcare Ltd. | Mainboard | ₹121.03 Cr | ₹91 | 17.67 | ₹91.73 | +0.80% | ₹15.16 (+0.66%) |
| Bio Medica Laboratories Ltd. | SME | ₹52.43 Cr | ₹139 | 13.03 | ₹115.80 | -16.69% | ₹135.00 (-1.39%) |
| Goldline Pharmaceutical Ltd. | SME | ₹11.61 Cr | ₹43 | 10.47 | ₹56.77 | +32.02% | ₹39.02 (+0.46%) |
| Speciality Medicines Ltd. | SME | ₹29.14 Cr | ₹124 | 9.27 | ₹125.90 | +1.53% | ₹178.30 (-1.49%) |
| Accretion Nutraveda Ltd. | SME | ₹24.77 Cr | ₹129 | 26.27 | ₹191.20 | +48.22% | ₹263.85 (+4.74%) |
| KRM Ayurveda Ltd. | SME | ₹77.49 Cr | ₹135 | 17.32 | ₹180.70 | +33.85% | ₹245.10 (-2.66%) |
| Curis Lifesciences Ltd. | SME | ₹27.52 Cr | ₹128 | 12.44 | ₹141.00 | +10.16% | ₹102.20 (+2.20%) |
| Aptus Pharma Ltd. | SME | ₹13.02 Cr | ₹70 | 11.29 | ₹84.84 | +21.20% | ₹242.90 (-1.64%) |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirements for setting up a new project to enhance existing manufacturing capacities and manufacture new products; and | 226.25 |
| 2 | General Corporate Purposes |
| KPI | Mar 31, 2025 |
|---|---|
| ROCE | 36.43% |
| Debt/Equity | 0.44 |
| RoNW | 33.91% |
| PAT Margin | 10.40% |
| EBITDA Margin | 16.36% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 0.44 | |
| Promoter Holding | 99.99% |
Lead Manager Reports
Cotec Healthcare IPO is a main-board IPO of 0 equity shares of the face value of ₹5 aggregating up to ₹[.] Crores. The issue is priced at To be declared. The minimum order quantity is .
The Cotec Healthcare IPO open and close dates are not available as of now.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Cotec Healthcare IPO using UPI as a payment gateway. Zerodha customers can apply in Cotec Healthcare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Cotec Healthcare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Cotec Healthcare IPO dates are not announced. Please check back again after some time.
Cotec Healthcare IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Cotec Healthcare IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Cotec Healthcare IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Cotec Healthcare IPO allotment status.
The Cotec Healthcare IPO listing date is not yet announced. The tentative date of listing is .
